Edition:
India

Tamara Mathias

U.S. launches four-state study to find ways to reduce opioid overdose deaths

19 Apr 2019

U.S. health officials on Thursday said they will spend $350 million in four states to study ways to best deal with the nation's opioid crisis on the local level, with a goal of reducing opioid-related overdose deaths by 40 percent over three years in selected communities in those states.

UnitedHealth sees minimal impact from rebate system overhaul

17 Apr 2019

UnitedHealth Group Inc said on Tuesday it expects minimal impact to its margins if the rebate system is overhauled but investors remained concerned about the impact of the Trump administration's proposal to end discounts from drugmakers.

Child abuse, recurrent depression linked to similar changes in brain

17 Apr 2019

(Reuters Health) - Abuse during childhood may cause physical changes to the human brain that in turn may render adults more vulnerable to depression, research suggests.

Dozens of clinics market risky cell therapies to treat eye disorders

04 Apr 2019

(Reuters Health) - - Scores of clinics across the United States directly advertise expensive - but unproven - cell therapy procedures to patients with serious eye diseases, often with devastating results, a new study warns.

EMA panel recommends approval of Bluebird Bio's first gene therapy

29 Mar 2019

A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod.

EMA panel recommends approval of Bluebird Bio's first gene therapy

29 Mar 2019

March 29 A European Medicines Agency panel on Friday recommended a conditional marketing approval for a gene therapy from Bluebird Bio Inc as a genetic blood disorder treatment, setting the stage for the U.S. biotech to win its first regulatory nod.

U.S. health insurer Centene to buy smaller rival WellCare for $15.3 billion

28 Mar 2019

U.S. health insurer Centene Corp on Wednesday said it would buy smaller rival WellCare Health Plans Inc for $15.27 billion, in a move to bulk up its government-backed Medicare and Medicaid businesses while reducing exposure to Obamacare healthcare exchanges. | Video

Women diagnosed years later than men for same diseases

26 Mar 2019

(Reuters Health) - For a wide range of diseases, diagnosis comes later in life for women than for men, according to a large Danish study.

UPDATE 3-Biogen scraps Alzheimer drug trials, wiping $17 billion off its market value

21 Mar 2019

* Analysts question Biogen's growth prospects (Adds context, details, background)

Low awareness of heart risks, heart health among young women

19 Mar 2019

(Reuters Health) - Young women are largely unaware of the risks they face from cardiovascular disease, even though it remains the top cause of death for American women, researchers warn.

World News